XORTX Therapeutics XRTX
NASDAQ XRTX
$1.73 +0.04 (+2.37%)
At close: Oct 1, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Goodwill impairment charges (2020)

Updated

XORTX Therapeutics (XRTX) posted Goodwill impairment charges of $1,833 for the year ended Dec 31, 2025.

Analysis

XORTX Therapeutics (XRTX) Goodwill impairment charges (2020) Analysis & Trends

  • The figure for the year ended Dec 31, 2025 stands as the lowest annual Goodwill impairment charges since the year ended Dec 31, 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 XORTX Therapeutics 1.60 Mn -1.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 64,562.00
API Access

XORTX Therapeutics Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=XRTX&period=max&api_key=YOUR_API_KEY